Bellus Health
Why Robinhood?
You can watch Bellus Health and buy or sell other stocks, ETFs, and their options commission-free!About BLU
BELLUS Health, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937 is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch.
BLU Key Statistics
Stock Snapshot
With a market cap of 1.87B, Bellus Health(BLU) trades at $14.74. The stock has a price-to-earnings ratio of -20.45.
During the trading day, Bellus Health(BLU) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Bellus Health(BLU) stock has reached 0, versus its average volume of 4.95M.
The stock's 52-week range extends from a low of $6.38 to a high of $14.76.
The stock's 52-week range extends from a low of $6.38 to a high of $14.76.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.